ArticleClinical pharmacokinetics2015

A physiologically based pharmacokinetic drug-disease model to predict carvedilol exposure in adult and paediatric heart failure patients by incorporating pathophysiological changes in hepatic and renal blood flows.

Muhammad Fawad Rasool et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.